Keynote speakers

Stephane Avril

Centre Ingénierie et Santé
Ecole des Mines de Saint-Etienne, Saint-Etienne, France

Talk: "Benefits and impact of digital twins in vascular mechanobiology"


Stéphane Avril received his PhD in mechanical and civil engineering in 2002 at Mines Saint-Etienne (France). Stéphane Avril is now a “Professeur de classe exceptionnelle” at Mines Saint-Etienne, Institut Mines Telecom in France. He is now the director of SAINBIOSE (INSERM endorsed laboratory with 150+ researchers). Within SAINBIOSE he leads a team working on cardiovascular dysfunction. Most of Stéphane’s research is aimed at improving the treatment of cardiovascular diseases by assisting physicians and surgeons with biomechanical numerical simulations. In 2017, Stéphane co-founded Predisurge, a spin-off company of IMT at Mines Saint-Etienne. PrediSurge offers innovative software solutions for patient-specific numerical simulation of surgical procedures. In 2024, Stéphane co-founded KaomX, another spin-off company of IMT at Mines Saint-Etienne. KaomX develops a novel imaging device for elasticity measurements in cell mechanobiology.





Piergiorgio Gentile

Centre for Biomaterials and Tissue Engineering
Universitat Politècnica de València, Valencia, Spain

Talk: "Layer-by-Layer Engineered Nanostructures for Precision Therapeutic Delivery"

Piergiorgio Gentile is a Biomedical Engineer with a PhD from Politecnico di Torino and international experience in Portugal, the UK, and Spain. Currently Piergiorgio Gentile is a distinguished investigator at Universitat Politècnica de València under the ATRAE Talent Programme. His interdisciplinary research focuses on biomaterials, regenerative medicine, and eco-friendly technologies, with applications in tissue engineering and drug delivery. He has led over 14 funded projects, hold five patents, and coordinate the Horizon Europe project HYDROHEAL. With 118 publications (h-index: 37) and a strong track record in academia and industry, he is actively contribute to innovation, mentoring, and science communication.





May Dongmei Wang

The Wallace H. Coulter Distinguished Faculty Fellow,
Professor and Director of Biomedical Big Data Initiative,
Georgia Distinguished Cancer Scholar, Kavli Fellow, FAIMBE
Petit Institute Faculty Fellow, FAIMBE, FIEEE, ELATES Fellow
Board of Directors in American Board of AI in Medicine
Georgia Institute of Technology and Emory University

Talk: "Challenges and Opportunities in Translating AI for Healthcare in The Era of GenA"

Dr. May Dongmei Wang is Wallace H. Coulter Distinguished Faculty Fellow and full professor of BME and ECE at Georgia Institute of Technology (GT) and Emory University (EU) in Atlanta, Georgia, USA. She received BEng from Tsinghua University China and MS/PhD from GT. She is Director of Biomedical Big Data Initiative, Georgia Distinguished Cancer Scholar, Board of Directors of American Board of AI in Medicine, Petit Institute Faculty Fellow, Kavli Fellow, AIMBE Fellow, IAMBE Fellow, IEEE Fellow, and ELATES Fellow. Dr. Wang works in Biomedical AI, Big Data, Health Informatics, and Metaverse for predictive, personalized, and precision health (pHealth). She published over 330 articles in referred journals and conference proceedings with more than 18K Google Scholar citations, and has delivered more than 340 invited and keynote lectures. She was awarded GT Outstanding Faculty Mentor for Undergrad Research, and EU MilliPub Award for a high-impact paper cited over 1,000 times. Dr. Wang is the Senior Editor for IEEE Journal of Biomedical and Health Informatics (JBHI), an Associate Editor for IEEE Transactions on BME and IEEE Reviews in BME, and a panelist for NIH CDMA Study Section, NSF Smart and Connect Health, and Brain Canada. Her research has been supported by NIH, NSF, CDC, Georgia Research Alliance, Georgia Cancer Coalition, Shriners’ Children, Children’s Health Care of Atlanta, Enduring Heart Foundation, Coulter Foundation, Imlay Foundation, Carol Ann and David Flanagan Foundation, Horizon Europe, Microsoft Research, HP, UCB, and Amazon.